Markets › United States › NAS › AKTS

Aktis Oncology Inc

NAS:AKTSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$15.11+0.33%At closeAt close · Tue 20 Oct · ≈ AED 55.49 · Market cap $840.41M · Next earnings Thu 12 Nov

Ratio	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	100.0%	100.0%	—	—
Operating margin	—	—	−3,500.3%	−1,149.5%	−1,149.5%	+0.0 pts
Net margin	—	—	−2,957.6%	−980.9%	−980.9%	+0.0 pts
EBITDA margin	—	—	−2,851.7%	−945.1%	—	—
Return on equity	93.2%	61.9%	50.1%	43.6%	43.6%	+0.0 pts
Return on assets	−13.0%	−23.4%	−13.5%	−24.1%	−24.1%	+0.0 pts
Return on capital employed	−14.9%	−30.0%	−16.9%	−32.0%	—	—
Debt / equity	−0.1×	−0.3×	−0.1×	−0.1×	−0.1×	+0.0%
Debt / assets	1.3%	11.0%	3.7%	4.4%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	25.1×	16.1×	16.0×	7.4×	7.4×	+0.0%
Quick ratio	25.1×	16.1×	16.0×	7.4×	—	—
Cash ratio	24.4×	4.7×	2.0×	1.2×	1.2×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	—	—